TNF and psoriasis vulgaris: This relationship is seemingly paradoxical given that four of the five TNF inhibitors are indicated as a treatment for a type of psoriasis, plaque psoriasis: certolizumab pegol12, adalimumab13, infliximab14, and etanercept, which is a fusion of the TNF receptor and the IgG1-Fc part of an antibody15.